Is Protalix Biotherapeutics, Inc. PLX stock halal to invest in?

No, as of August 2026, Protalix Biotherapeutics, Inc. stock (PLX) is not currently classified as a Shariah compliant stock. This verdict follows the screening methodology of AAOIFI (the Accounting and Auditing Organization for Islamic Financial Institutions), whose Shariah Standard No. 21 is the leading global benchmark for screening halal stocks. To qualify as halal under this standard, a company must keep non-permissible income below 5% of total revenue, keep both interest-bearing investments and interest-bearing debt below 30% of market capitalisation, and have no impermissible preference share structure. Protalix Biotherapeutics, Inc. currently does not meet the threshold for the interest-bearing investments screen. Because screenings are refreshed monthly as new financial reports are published, a non-compliant stock can regain compliant status if its financial structure changes. You can track the latest status of Protalix Biotherapeutics, Inc. and discover Shariah compliant alternatives among the halal stocks in the Tabadulat app.

How often is Protalix Biotherapeutics, Inc. PLX reviewed for Shariah compliance?

Tabadulat reviews Protalix Biotherapeutics, Inc. PLX for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for Protalix Biotherapeutics, Inc. reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does Protalix Biotherapeutics, Inc. PLX pass the AAOIFI Non Permissible Income criteria?

Yes, as of August 2026, Protalix Biotherapeutics, Inc. stock (PLX) passes the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. Protalix Biotherapeutics, Inc.'s income from non-permissible sources is currently within this 5% threshold. Even permissible levels of incidental impure income should still be purified: investors donate the corresponding share of dividends to charity, as reflected in the stock's purification factor. This screen is reassessed monthly using the company's latest financial disclosures.

Does Protalix Biotherapeutics, Inc. PLX pass the AAOIFI Interest Bearing Investments criteria?

No, as of August 2026, Protalix Biotherapeutics, Inc. stock (PLX) does not pass the AAOIFI interest-bearing investments screen. Under AAOIFI Shariah Standard No. 21, the cash a company places in interest-earning instruments (such as conventional deposits, bonds, treasury bills and money-market funds) must remain below 30% of its market capitalisation. Protalix Biotherapeutics, Inc.'s interest-bearing investments currently exceed this 30% limit, meaning too large a share of the company's value derives from riba-based instruments for the stock to qualify as halal on this criterion. The ratio moves with both the balance sheet and the share price, and is reassessed monthly.

Does Protalix Biotherapeutics, Inc. PLX pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of August 2026, Protalix Biotherapeutics, Inc. stock (PLX) passes the AAOIFI interest-bearing debt screen. Under AAOIFI Shariah Standard No. 21, a company's borrowings that accrue interest (conventional bank loans, bonds and similar riba-based financing) must remain below 30% of its market capitalisation. This cap limits shareholders' exposure to interest-based leverage. Protalix Biotherapeutics, Inc.'s interest-bearing debt is currently within the 30% threshold. Because market capitalisation changes daily, a company's debt ratio can drift toward or away from the limit even without new borrowing, which is why this screen is reassessed every month.

What is the dividend purification factor for Protalix Biotherapeutics, Inc. PLX stock?

Protalix Biotherapeutics, Inc. (PLX) is currently classified as not Shariah compliant, so no dividend purification factor applies, because purification factors are calculated only for stocks that pass the AAOIFI screens. Purification (tazkiyah) is the practice of donating to charity the small portion of dividend income that stems from incidental non-permissible sources, such as interest earned on a compliant company's cash deposits. For non-compliant stocks the issue is not purification but eligibility: under AAOIFI Shariah Standard No. 21 the stock does not currently qualify as a halal investment. If Protalix Biotherapeutics, Inc. returns to compliance in a future monthly screening, its purification factor will be published alongside its updated status in the Tabadulat app.

Does Protalix Biotherapeutics, Inc. PLX pass the AAOIFI Preference Share screen?

Yes, as of August 2026, Protalix Biotherapeutics, Inc. stock (PLX) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. Protalix Biotherapeutics, Inc. has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

English

العربية

Protalix Biotherapeutics, Inc.

NYSE

Shariah-Compliant

Not Shariah

PLX

About

Protalix Biotherapeutics, Inc.

PLX

Protalix Biotherapeutics Inc. is a biopharmaceutical company focused on developing and manufacturing therapeutic proteins using its proprietary plant cell-based expression system. This innovative platform allows for the production of recombinant proteins, offering advantages such as scalability and cost-effectiveness compared to traditional mammalian cell culture methods. Protalix is prominently engaged in advancing solutions within the rare diseases sector, exemplifying its commitment to addressing unmet medical needs. One of its leading products targets Gaucher disease, a hereditary enzyme deficiency disorder. Serving global pharmaceutical markets, Protalix collaborates with international partners to commercialize and distribute its therapies. The company’s research and development efforts emphasize expanding the therapeutic potential of its platform, thereby contributing significantly to the biotechnology industry. Based in the biotechnology hub of Israel, Protalix Biotherapeutics Inc. plays an important role in the biopharmaceutical field, pushing the horizons of innovative treatment options and impacting the healthcare sector by striving to improve patient outcomes for rare, genetic conditions.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

213

Website:

https://www.protalix.com

PLX

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in halal stocks the same day.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Protalix Biotherapeutics, Inc.

About

Protalix Biotherapeutics, Inc.

PLX

Frequently asked questions

Is Protalix Biotherapeutics, Inc. PLX stock halal to invest in?

How often is Protalix Biotherapeutics, Inc. PLX reviewed for Shariah compliance?

Does Protalix Biotherapeutics, Inc. PLX pass the AAOIFI Non Permissible Income criteria?

Does Protalix Biotherapeutics, Inc. PLX pass the AAOIFI Interest Bearing Investments criteria?

Does Protalix Biotherapeutics, Inc. PLX pass the AAOIFI Interest Bearing Debt criteria?

What is the dividend purification factor for Protalix Biotherapeutics, Inc. PLX stock?

Does Protalix Biotherapeutics, Inc. PLX pass the AAOIFI Preference Share screen?

Can I buy Protalix Biotherapeutics (PLX) stock on Tabadulat?

Open your account.

Deposit.

Screen.